United States - English - NLM (National Library of Medicine)

fondel chemicals ltd. - zinc sulfate monohydrate (unii: ptx099xsf1) (zinc cation - unii:13s1s8sf37) - zinc cation 0.4 kg in 1.6 kg - purpose:zinc sulphate monohydrate powder is used as an aid in hoof rot management under veterinary guidance. warnings: - zinc can be toxic to sheep. do not allow animals to eat or drink the zinc sulphate powder or hoof bath solution. - know the volume of the hoof bath and calculate the amount of zinc sulphate carefully. - do not overdose by using more zinc sulphate than what is recommended by your veterinarian.

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

zinc sulfate monohydrate (equivalent to 20mg elemental zinc) -

Philippines - English - FDA (Food And Drug Administration)

ritemed phils., inc. - zinc sulfate monohydrate - oral solution - 55 mg/5 ml (equivalent to 20 mg elemental zinc)

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: n/a; distributor: aisec farma corporation - zinc (as sulfate monohydrate) - 55 mg/5 ml syrup (equivalent to 20 mg elemental zinc/5 ml)

Philippines - English - FDA (Food And Drug Administration)

remed pharmaceuticals, inc.; importer: n/a; distributor: n/a - zinc sulfate (as monohydrate) - syrup - 56 mg (equivalent to 20 mg elemental zinc)/5 ml

Philippines - English - FDA (Food And Drug Administration)

vitalink health products, inc.; distributor: altomed pharmaceuticals, inc. - zinc (as zinc sulfate monohydrate) - syrup (orange flavor) - 20 mg/5 ml (equivalent to 55 mg zinc sulfate monohydrate)

Philippines - English - FDA (Food And Drug Administration)

vitalink health products, inc.; distributor: altomed pharmaceuticals, inc. - zinc (as zinc sulfate monohydrate) - syrup (oral drops) (orange flavor) - 10 mg/ml (equivalent to 27.5 mg zinc sulfate monohydrate)

Philippines - English - FDA (Food And Drug Administration)

drugmaker's laboratories, inc. - zinc sulfate monohydrate - syrup (oral drops) - 10 mg/ ml

Philippines - English - FDA (Food And Drug Administration)

drugmaker's laboratories, inc. - zinc sulfate monohydrate - syrup - 20 mg/5 ml

United States - English - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate (unii: 89ds0h96tb) (zinc cation - unii:13s1s8sf37) - zinc sulfate injection is indicated in adult and pediatric patients as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. zinc sulfate injection is contraindicated in patients with known hypersensitivity to zinc [see warnings and precautions (5.6)] risk summary administration of the approved recommended dose of zinc sulfate injection in parenteral nutrition is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with intravenous zinc sulfate.  the estimated background risk of major birth defects and miscarriage for the indicated populations is unknown.  all pregnancies have a background risk of birth defect, loss, or other adverse outcomes.  in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. clinical considerations disease-associated maternal and/or embryo-fetal risk deficiency of trace elements, including zinc, is associated with adverse pregnancy and fetal outcomes. pregnant women have an increased metabolic demand for trace elements, including zinc.  parenteral nutrition with zinc should be considered if a pregnant woman’s nutritional requirements cannot be fulfilled by oral or enteral intake. risk summary zinc is present in human milk. administration of the approved recommended dose of zinc sulfate injection in parenteral nutrition is not expected to cause harm to a breastfed infant. there is no information on the effects of zinc sulfate on milk production. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for zinc sulfate injection and any potential adverse effects on the breastfed infant from zinc sulfate injection or from the underlying maternal condition. zinc sulfate injection is approved for use in the pediatric population, including neonates, as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. safety and dosing recommendations in pediatric patients are based on published literature describing controlled studies of zinc-containing products in pediatric patients [see dosage and administration (2.2)] . because of immature renal function, preterm infants receiving prolonged parenteral nutrition treatment with zinc sulfate injection may be at higher risk of aluminum toxicity [see warnings and precautions (5.3)] . reported clinical experience with intravenous zinc sulfate has not identified a difference in zinc requirements between elderly and younger patients.  in general, dose selection should be individualized based on the patient’s clinical condition, nutritional requirements, and additional nutritional intake provided orally or enterally to the patient.